114 related articles for article (PubMed ID: 23000415)
1. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
2. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
3. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
4. Trends Over Time in Tobacco-Specific Nitrosamines (TSNAs) in Whole Tobacco and Smoke Emissions From Cigarettes Sold in Canada.
Czoli CD; Hammond D
Nicotine Tob Res; 2018 Apr; 20(5):649-653. PubMed ID: 28595283
[TBL] [Abstract][Full Text] [Related]
5. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
6. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
[TBL] [Abstract][Full Text] [Related]
7. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Stepanov I; Jensen J; Biener L; Bliss RL; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Oct; 14(10):1241-5. PubMed ID: 22259150
[TBL] [Abstract][Full Text] [Related]
8. Tobacco alkaloids and tobacco-specific nitrosamines in dust from homes of smokeless tobacco users, active smokers, and nontobacco users.
Whitehead TP; Havel C; Metayer C; Benowitz NL; Jacob P
Chem Res Toxicol; 2015 May; 28(5):1007-14. PubMed ID: 25794360
[TBL] [Abstract][Full Text] [Related]
9. Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products.
Stepanov I; Yershova K; Carmella S; Upadhyaya P; Hecht SS
Nicotine Tob Res; 2013 Jul; 15(7):1305-10. PubMed ID: 23212437
[TBL] [Abstract][Full Text] [Related]
10. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
[TBL] [Abstract][Full Text] [Related]
11. Intake of tobacco nitrosamines of smokers in various provinces of China and their cancer risk: A meta-analysis.
Li X; Ye Z; Wang J; Lin P; Zhang X; Xie S; Chen C
J Environ Sci (China); 2024 Jul; 141():249-260. PubMed ID: 38408825
[TBL] [Abstract][Full Text] [Related]
12. From cultivation to cancer: formation of
Stanfill SB; Hecht SS; Joerger AC; González PJ; Maia LB; Rivas MG; Moura JJG; Gupta AK; Le Brun NE; Crack JC; Hainaut P; Sparacino-Watkins C; Tyx RE; Pillai SD; Zaatari GS; Henley SJ; Blount BC; Watson CH; Kaina B; Mehrotra R
Crit Rev Toxicol; 2023 Nov; 53(10):658-701. PubMed ID: 38050998
[TBL] [Abstract][Full Text] [Related]
13. High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus.
Stepanov I; Gupta PC; Dhumal G; Yershova K; Toscano W; Hatsukami D; Parascandola M
Tob Control; 2015 Dec; 24(e4):e271-4. PubMed ID: 25217658
[TBL] [Abstract][Full Text] [Related]
14. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
15. Regulation of toxic contents of smokeless tobacco products.
Kumar A; Bhartiya D; Kaur J; Kumari S; Singh H; Saraf D; Sinha DN; Mehrotra R
Indian J Med Res; 2018 Jul; 148(1):14-24. PubMed ID: 30264750
[TBL] [Abstract][Full Text] [Related]
16. Analysis of waterpipe aerosol constituents in accordance with the ISO standard 22486.
Jaccard G; Tafin Djoko D; Korneliou A; Belushkin M
Toxicol Rep; 2020; 7():1344-1349. PubMed ID: 33102137
[TBL] [Abstract][Full Text] [Related]
17. Evidence supporting product standards for carcinogens in smokeless tobacco products.
Hatsukami DK; Stepanov I; Severson H; Jensen JA; Lindgren BR; Horn K; Khariwala SS; Martin J; Carmella SG; Murphy SE; Hecht SS
Cancer Prev Res (Phila); 2015 Jan; 8(1):20-6. PubMed ID: 25524878
[TBL] [Abstract][Full Text] [Related]
18. Risk for oral cancer from smokeless tobacco.
Janbaz KH; Qadir MI; Basser HT; Bokhari TH; Ahmad B
Contemp Oncol (Pozn); 2014; 18(3):160-4. PubMed ID: 25520574
[TBL] [Abstract][Full Text] [Related]
19. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
Mallock N; Schulz T; Malke S; Dreiack N; Laux P; Luch A
Tob Control; 2024 Feb; 33(2):193-199. PubMed ID: 38378209
[TBL] [Abstract][Full Text] [Related]
20. The acrylamide content of smokeless tobacco products.
McAdam K; Kimpton H; Vas C; Rushforth D; Porter A; Rodu B
Chem Cent J; 2015; 9():56. PubMed ID: 26473006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
